Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/347991
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUNIVERSIDADE ESTADUAL DE CAMPINASpt_BR
dc.contributor.authorunicampAppenzeller, Simone-
dc.typeArtigopt_BR
dc.titleCognitive impairment in antiphospholipid syndrome: evidence from animal modelspt_BR
dc.contributor.authorAppenzeller, Simone-
dc.subjectSíndrome antifosfolipídicapt_BR
dc.subjectComprometimento cognitivo levept_BR
dc.subject.otherlanguageAntiphospholipid syndromept_BR
dc.subject.otherlanguageCognitive dysfunctionpt_BR
dc.description.abstractAlthough antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, its inflammatory nature has been increasingly recognized in recent years. Stroke and transitory ischemic attacks are the neurological manifestations included in APS criteria, however many other neurological involvements have been attributed to antiphospholipid antibodies (aPL), such as seizures, transverse myelitis, and cognitive impairment. In this article we will review evidence from animal model that explain the role of aPL in cognitionpt_BR
dc.relation.ispartofClinical rheumatologypt_BR
dc.relation.ispartofabbreviationClin. rheumatol.pt_BR
dc.publisher.cityLondonpt_BR
dc.publisher.countryReino Unidopt_BR
dc.publisherSpringerpt_BR
dc.date.issued2012-
dc.date.monthofcirculationMar.pt_BR
dc.language.isoengpt_BR
dc.description.volume31pt_BR
dc.description.issuenumber3pt_BR
dc.description.firstpage403pt_BR
dc.description.lastpage406pt_BR
dc.rightsFechadopt_BR
dc.sourceWOSpt_BR
dc.identifier.issn0770-3198pt_BR
dc.identifier.eissn1434-9949pt_BR
dc.identifier.doi10.1007/s10067-011-1922-zpt_BR
dc.identifier.urlhttps://link.springer.com/article/10.1007/s10067-011-1922-zpt_BR
dc.description.sponsorshipCONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQpt_BR
dc.description.sponsorshipFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPpt_BR
dc.description.sponsordocumentnumber300447/2009-4; 300665/2009-1pt_BR
dc.description.sponsordocumentnumber2008/02917-0; 2009/06049-6pt_BR
dc.date.available2020-08-25T20:01:53Z-
dc.date.accessioned2020-08-25T20:01:53Z-
dc.description.provenanceSubmitted by Cintia Oliveira de Moura (cintiaom@unicamp.br) on 2020-08-25T20:01:53Z No. of bitstreams: 0. Added 1 bitstream(s) on 2021-01-04T15:14:10Z : No. of bitstreams: 1 000303448900001.pdf: 220803 bytes, checksum: df18d2b12c5f62f4a3c95aebcaf97d7a (MD5)en
dc.description.provenanceMade available in DSpace on 2020-08-25T20:01:53Z (GMT). No. of bitstreams: 0 Previous issue date: 2012en
dc.identifier.urihttp://repositorio.unicamp.br/jspui/handle/REPOSIP/347991-
dc.contributor.departmentDepartamento de Clínica Médicapt_BR
dc.contributor.unidadeFaculdade de Ciências Médicaspt_BR
dc.identifier.source000303448900001pt_BR
dc.creator.orcid0000-0001-5075-4474pt_BR
dc.type.formArtigo de revisãopt_BR
dc.description.sponsorNoteFederico Foundationpt_BR
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
000303448900001.pdf215.63 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.